×
Artiva Biotherapeutics Price/Book Ratio 1971-1970 | ARTV
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Artiva Biotherapeutics price/book ratio from 1971 to 1970. Price/book ratio can be defined as
View More
Artiva Biotherapeutics Price/Book Ratio 1971-1970 | ARTV
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Artiva Biotherapeutics price/book ratio from 1971 to 1970. Price/book ratio can be defined as
Related Stocks
Company Name
Market
Cap
Amgen (AMGN)
$180.1B
Regeneron Pharmaceuticals (REGN)
$127.1B
Vertex Pharmaceuticals (VRTX)
$126.3B
Gilead Sciences (GILD)
$103.5B
Bristol Myers Squibb (BMY)
$101.3B
CSL (CSLLY)
$97.4B
GSK (GSK)
$90.3B
Alnylam Pharmaceuticals (ALNY)
$34.7B
Argenex SE (ARGX)
$32.2B
BioNTech SE (BNTX)
$29.4B
Biogen (BIIB)
$29.1B
Moderna (MRNA)
$26.6B
Illumina (ILMN)
$20.6B
BeiGene (BGNE)
$19.1B
Genmab (GMAB)
$17.6B
BioMarin Pharmaceutical (BMRN)
$13.3B
Exact Sciences (EXAS)
$12.8B
Incyte (INCY)
$12.8B
Vaxcyte (PCVX)
$12.8B
Insmed (INSM)
$12.6B
Bio-Techne Corp (TECH)
$11.9B
Sarepta Therapeutics (SRPT)
$11.9B
QIAGEN (QGEN)
$10.6B
Legend Biotech (LEGN)
$9.4B
Bio-Rad Laboratories (BIO.B)
$9.1B
Roivant Sciences (ROIV)
$8.9B
Ascendis Pharma (ASND)
$8.1B
Halozyme Therapeutics (HALO)
$8B
Intra-Cellular Therapies (ITCI)
$8B
Repligen (RGEN)
$7.8B